Combination of Toripalimab and JS004 Therapy for ccRCC

Clinical trial NCT06690697 · RECRUITING

Trial details

NCT number: NCT06690697
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2024-06-01
Primary completion: 2026-06-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.